Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast Cancer

Evaluation of Cancer-Based Criteria for Use in MainstreamBRCA1andBRCA2Genetic Testing in Patients With Breast Cancer

Importance: Increasing BRCA1 and BRCA2 (collectively termed herein as BRCA) gene testing is required to improve cancer management and prevent BRCA-related cancers. Objective: To evaluate mainstream genetic testing using cancer-based criteria in patients with cancer. Design, Setting, and Participants...

Full description

Bibliographic Details
Main Authors:	Kemp, Zoe, Turnbull, Alice, Yost, Shawn, Seal, Sheila, Mahamdallie, Shazia, Poyastro-Pearson, Emma, Warren-Perry, Margaret, Eccleston, Anthony, Tan, Min Min, Teo, Soo Hwang, Turner, Nicholas, Strydom, Ann, George, Angela, Rahman, Nazneen
Format:	Article
Published:	JAMA Network 2019
Subjects:	R Medicine

Similar Items

Inherited mutations inBRCA1andBRCA2in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia
by: Wen, Wei Xiong, et al.
Published: (2017)

CoverView: a sequence quality evaluation tool for next generation sequencing data [version 1; referees: 2 approved]
by: Márton Münz, et al.
Published: (2018-04-01)

Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
by: Quratul Ain, et al.
Published: (2023-02-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

Patients' views of treatment-focused genetic testing (TFGT): some lessons for the mainstreaming of BRCA1 and BRCA2 testing
by: Wright, S, et al.
Published: (2018)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-08-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

LOSS OF HETEROZYGOSITY IN THE BRCA1 AND BRCA2 LOCUS IN BREAST CANCER
by: M. M. Tsyganov, et al.
Published: (2020-07-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Risk assessment for hereditary breast cancer: BRCA1 and BRCA2
by: Kendra-Ann I. Seenandan-Sookdeo, et al.
Published: (2010-07-01)

BRCA1 and BRCA2 and Inherited Predisposition to Breast and Ovarian Cancers
by: Patricia N. Tonin
Published: (2002-12-01)

Comparing Prognosis for <i>BRCA1</i>, <i>BRCA2</i>, and Non-BRCA Breast Cancer
by: Pedro Antunes Meireles, et al.
Published: (2023-12-01)

Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2 Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
by: Steven A Narod, et al.
Published: (2011-10-01)

Beyond breast and ovarian cancers: PARP inhibitors for BRCA mutation-associated and BRCA-like solid tumors
by: Ciara C. O'Sullivan, et al.
Published: (2014-02-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
by: Melissa S Cline, et al.
Published: (2018-12-01)

Experience in treating BRCA-associated breast cancer. The BRCA-history of a family
by: A. V. Sultanbaev, et al.
Published: (2021-08-01)

The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
by: I A Demidova
Published: (2017-01-01)

BRCA1 and BRCA2 Variation in Taiwanese General Population and the Cancer Cohort
by: Jiasheng Chian, et al.
Published: (2021-06-01)

Predominance of <i>BRCA2</i> Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with <i>BRCA1</i> or <i>BRCA2</i> Mutation
by: Pascal Pujol, et al.
Published: (2022-07-01)

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
by: Li, J, et al.
Published: (2018)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America
by: Josef S. Herzog, et al.
Published: (2021-08-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer
by: Mohammad Hassan Tajadini, et al.
Published: (2013-02-01)

BRCA1 and BRCA2 Genetic Testing in Breast and/or Ovarian Cancer Families in Iran
by: Fatemeh Keshavarzi, et al.
Published: (2010-01-01)

Prevalance of <it>BRCA1</it> and <it>BRCA2</it> mutations in familial breast cancer patients in Lebanon
by: Jalkh Nadine, et al.
Published: (2012-06-01)

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
by: Roshni D. Kalachand, et al.
Published: (2020-09-01)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2022-04-01)

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families
by: Kang, P., et al.
Published: (2010)

Pancreatic Cancer: Beyond Brca Mutations
by: Vincenzo Ricci, et al.
Published: (2022-12-01)

The BRCA Gene in Epithelial Ovarian Cancer
by: Luisa Sánchez-Lorenzo, et al.
Published: (2022-02-01)

Characterization of BRCA Deficiency in Ovarian Cancer
by: Giovanna Barbero, et al.
Published: (2023-02-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
by: Kara N. Maxwell, et al.
Published: (2017-08-01)

Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients
by: Hasmad, HN, et al.
Published: (2015)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations
by: Bancroft, E, et al.
Published: (2018)

Role of BRCA 1 и BRCA 2 gene mutations in the occurrence of male breast cancer
by: A. V. Bykova, et al.
Published: (2014-07-01)

Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation
by: Carol A. Mansfield, et al.
Published: (2020-09-01)

BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review
by: Hossein Neamatzadeh, et al.
Published: (2015-01-01)

Identification of Eleven Novel BRCA Mutations in Tunisia: Impact on the Clinical Management of BRCA Related Cancers
by: Yosr Hamdi, et al.
Published: (2021-08-01)

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
by: Nicolai Juul Birkbak, et al.
Published: (2013-01-01)